Literature DB >> 8660964

The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type I interferons and interleukin-7.

J Wang1, H Walker, Q Lin, N Jenkins, N G Copeland, T Watanabe, P D Burrows, M D Cooper.   

Abstract

The BP-1/6C3 antigen is a homodimeric, phosphorylated type II membrane integral glycoprotein expressed on immature B-lineage cells, bone marrow stromal cells, thymic cortical epithelial cells, endothelial cells, enterocytes, and renal proximal tubular cells. Biochemical and molecular analysis identified BP-1 as glutamyl aminopeptidase, an ectoenzyme that catalyzes the hydrolysis of acidic amino acid residues from the amino termini of regulatory peptides. We have isolated genomic clones that encode the BP-1 gene (gene symbol Enpep). The gene spans more than 110 kb and contains 20 exons. Except for the first and the last exons, it is composed of small exons ranging from 56 to 171 bp that are separated by introns ranging from less than 100 bp to approximately 10 kb. The zinc binding motif HEXXH and the glutamic acid residue 19 amino acids downstream, which also binds zinc, are encoded in exons 5 and 6. Primer extension analysis revealed a common major transcriptional start site in a pre-B cell line, in a bone marrow stromal cell line, and in kidney cells. The promoter region contains a TATA-like element and potential DNA-binding motifs for lymphocyte-specific transcription factors including Ikaros, BSAP, PU.1, and octamer binding proteins, as well as DNA binding motifs for several ubiquitous transcription factors. An interferon responsive element also located in the promoter region appeared to be functional, since type I interferons (IFN-alpha/IFN-beta) upregulated BP-1 expression in pre-B cell lines. A 2.1-kb promoter fragment, when fused to a luciferase reporter gene, was able to drive luciferase expression in pre-B cells, which normally express BP-1, and the Ag8 cells, in which BP-1 expression is extinguished. The BP-1/ Enpep gene was localized to a distal region of mouse chromosome 3 in a region homologous to human chromosome 4q25. Interestingly, while interleukin-7 (IL-7) induced both cell growth and increased BP-1 expression, IFN-alpha/IFN-beta upregulated BP-1 expression but inhibited IL-7 induced proliferation. This finding indicates that the upregulated BP-1 expression can be disassociated from the cell growth signal.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660964     DOI: 10.1006/geno.1996.0180

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

1.  Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin.

Authors:  K Hahm; B S Cobb; A S McCarty; K E Brown; C A Klug; R Lee; K Akashi; I L Weissman; A G Fisher; S T Smale
Journal:  Genes Dev       Date:  1998-03-15       Impact factor: 11.361

2.  NT-proBNP as a marker of cardiopulmonary status in sickle cell anaemia in Africa.

Authors:  Zakari Y Aliyu; Aisha Suleiman; Ester Attah; Aisha I Mamman; Aliyu Babadoko; Mehdi Nouraie; Laurel Mendelsohn; Gregory J Kato; Victor R Gordeuk; Mark T Gladwin
Journal:  Br J Haematol       Date:  2010-04-16       Impact factor: 6.998

3.  Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS).

Authors:  Stephen Tonna; Savita V Dandapani; Andrea Uscinski; Gerald B Appel; Johannes S Schlöndorff; Kang Zhang; Bradley M Denker; Martin R Pollak
Journal:  Gene       Date:  2007-12-03       Impact factor: 3.688

4.  Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice.

Authors:  Takashi Mitsui; Seiji Nomura; Mayumi Okada; Yasumasa Ohno; Honami Kobayashi; Yutaka Nakashima; Yasutaka Murata; Mikihito Takeuchi; Naohiko Kuno; Tetsuo Nagasaka; Jiyang O-Wang; Max D Cooper; Shigehiko Mizutani
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

5.  The transcription factor early growth response 1 (Egr-1) advances differentiation of pre-B and immature B cells.

Authors:  A Dinkel; K Warnatz; B Ledermann; A Rolink; P F Zipfel; K Bürki; H Eibel
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

6.  Impairment of T and B cell development by treatment with a type I interferon.

Authors:  Q Lin; C Dong; M D Cooper
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

7.  Molecular characterization of a puromycin-insensitive leucyl-specific aminopeptidase, PILS-AP.

Authors:  L Schomburg; H Kollmus; S Friedrichsen; K Bauer
Journal:  Eur J Biochem       Date:  2000-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.